---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-024957"
form_type: "8-K"
ticker: "TPB"
cik: "0001290677"
company_name: "Turning Point Brands, Inc."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T18:58:08.137208+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Turning Point Brands Q2 net sales up 25% to $116.6M; Modern Oral surges 651%; raises guidance

## Summary
- Net sales $116.6M (+25.1% YoY); net income $14.5M (+11.3%); diluted EPS $0.79.
- Modern Oral sales $30.1M (+651% YoY), now 26% of total sales; Stoker's segment up 62.9%.
- Adjusted EBITDA $30.5M (+14.8%); adjusted diluted EPS $0.98 vs $0.89 prior year.
- Raises 2025 Adj. EBITDA guidance to $110-114M (from $108-113M).
- Raises 2025 Modern Oral sales guidance to $100-110M (from $80-95M).

## SEC filing metadata
- accession: 0001437749-25-024957
- form_type: 8-K
- ticker: TPB
- cik: 0001290677
- company_name: Turning Point Brands, Inc.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1290677/000143774925024957/0001437749-25-024957-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1290677/000143774925024957/tpb20250728_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-024957
- JSON: https://secwatch.observer/filing/0001437749-25-024957.json
- Plain text: https://secwatch.observer/filing/0001437749-25-024957.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.